18 articles for MJ Kurth
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
High-Potency Phenylquinoxalinone Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activators.
University of California
¿F508-CFTR correctors: synthesis and evaluation of thiazole-tethered imidazolones, oxazoles, oxadiazoles, and thiadiazoles.
Wuhan University of Science and Technology
Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.
University of California
ABSOLUTE CONFIGURATION AND BIOLOGICAL PROPERTIES OF ENANTIOMERS OF CFTR INHIBITOR BPO-27.
University of California
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrinavß3.
University of California
Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease.
University of California
Targeting multiple chorismate-utilizing enzymes with a single inhibitor: validation of a three-stage design.
University of California
Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.
University of California Davis
Slow-binding human serine racemase inhibitors from high-throughput screening of combinatorial libraries.
University of California
3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.
University of California
Synthesis and evaluation of tetrahydropyrazolopyridine inhibitors of anion exchange protein SLC26A4 (pendrin).
University of California
Constrained bithiazoles: small molecule correctors of defective ΔF508-CFTR protein trafficking.
University of California
Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis.
University of California Davis
Structure-activity relationships of cyanoquinolines with corrector-potentiator activity in ΔF508 cystic fibrosis transmembrane conductance regulator protein.
University of California Davis
Fluorinated ΔF508-CFTR correctors and potentiators for PET imaging.
University of California Davis
Pyrazolylthiazole as DeltaF508-cystic fibrosis transmembrane conductance regulator correctors with improved hydrophilicity compared to bithiazoles.
University of California Davis
4'-Methyl-4,5'-bithiazole-based correctors of defective delta F508-CFTR cellular processing.
University of California
